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The 1.7 AÊ Crystal Structure of Human Cell Cycle
Checkpoint Kinase Chk1: Implications
for Chk1 Regulation
et al., 1998). In S. pombe, Chk1 is essential for cell cycle
arrest following DNA damage (Walworth et al., 1993;
Walworth and Bernards, 1996; Lindsay et al., 1998). A
checkpoint role for Chk1 has also been uncovered in
Xenopus (Kumagai et al., 1998), and in cells from individ-
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Agouron Pharmaceuticals, Inc. uals defective in ATM (Chen et al., 1999). In this latter
case, overexpression of Chk1 rescued the G2 check-3565 General Atomics Court
San Diego, California 92121 point defect of this cancer-prone phenotype, an out-
come consistent with a G2 delay induced by overexpres-
sion of Chk1 (Walworth et al., 1993; Chen et al., 1999).
In yeast, Chk1 also phosphorylates Wee1 (O'Connell etSummary
al., 1997) and Pds1 (Sanchez et al., 1999). In the case
of Pds1, which regulates DNA damage±induced arrest inThe checkpoint kinase Chk1 is an important mediator
of cell cycle arrest following DNA damage. The 1.7 AÊ S. cerevisiae, Chk1-dependent phosphorylation of Pds1
correlates with Pds1 resistance to degradation (Sanchezresolution crystal structures of the human Chk1 kinase
domain and its binary complex with an ATP analog et al., 1999). Taken together, these results point to an
important role for the Chk1 in regulating cell cycle arresthas revealed an identical open kinase conformation.
The secondary structure and side chain interactions following DNA damage.
The human Chk1 is a nuclear protein of 476 aminostabilize the activation loop of Chk1 and enable kinase
activity without phosphorylation of the catalytic do- acids (Sanchez et al., 1997). It contains a highly con-
served N-terminal kinase domain (residues 1±265), amain. Molecular modeling of the interaction of a
Cdc25C peptide with Chk1 has uncovered several con- flexible linker region, and a less conserved C-terminal
region with undefined function. The crystal structure ofserved residues that are important for substrate selec-
tivity. In addition, we found that the less conserved the human Chk1 kinase domain (residues 1±289) de-
scribed here provides important insights into Chk1 regu-C-terminal region negatively impacts Chk1 kinase ac-
tivity. lation and substrate selectivity.
ResultsIntroduction
The Overall StructureDNA damage activates a series of checkpoints that ar-
The crystal structures of Chk1KD apoenzyme and itsrest cell cycle progression for repair of damaged DNA
binary complex with an ATP analog, AMP-PNP, have(Hartwell and Weinert, 1989; Weinert, 1998). These
been determined to 1.7 AÊ resolution. Chk1KD containscheckpoints interfere with the cyclin-dependent kinases
a C-terminal 63His tag and the first 289 amino acids of(Cdks), which coordinate cell cycle progression (Murray,
human Chk1, consisting of the conserved kinase domain1992; Elledge, 1996; O'Connor, 1997). At the G2 check-
and part of the linker region. Table 1 summarizes ourpoint in most species, DNA damage blocks the removal
crystallographic analysis. Chk1KD has a canonical ki-of Cdc2-inhibitory phosphorylations (Thr14 and Tyr15
nase two-lobe fold with the ATP-binding cleft residingof Cdc2) to prevent activation of this mitosis promoting
between the two lobes (Figure 1A). Sequence homologyCdk (Jin et al., 1996; Poon et al., 1996; Rhind et al., 1997).
in the Chk1 kinase domain suggests overall structuralDephosphorylation and thereby activation of Cdc2 is
conservation across species (Figure 2). Residues thatcarried out in human cells by the dual specificity Cdc25C
are not modeled in the current structure, due to lack ofphosphatase (Millar et al., 1991; Lee et al., 1992; Hoff-
electron density, are not conserved among Chk1 pro-mann et al., 1993). Activation of the Cdc25C is proposed
teins (Figures 1 and 2).to occur through an autocatalytic feedback loop mecha-
There is no conformational change in Chk1KD be-nism involving nuclear Cdc2 (Hoffmann et al., 1993). The
tween the AMP-PNP bound binary complex and thenuclear accumulation of Cdc25C is negatively regulated
apoenzyme. In both structures, the ATP binding site,by phosphorylation at Ser216, which enables binding to
catalytic residues, and the activation loop are well or-14±3±3 proteins (Peng et al., 1997; Sanchez et al., 1997;
dered. The conformation of Chk1KD is close to activeDalal et al., 1999). In S. pombe, 14±3±3 proteins shuttle
kinase structures. The N- and C-terminal lobes can bethe phosphorylated Cdc25 out of nucleus after DNA
separately superimposed on the corresponding lobesdamage (Lopez-Girona et al., 1999), and the G2 check-
of phosphorylase kinase (PhK, PDB code 2PHK) (Lowepoint is abrogated by expressing a Cdc25 mutant se-
et al., 1997), but, the two lobes of Chk1KD adopt averely impaired for 14±3±3 binding (Zeng et al., 1998).
more open conformation compared to PhK (Figure 1B).One of the kinases that phosphorylates Cdc25C on
A nearly identical Chk1KD conformation has been ob-Ser216 is Chk1, which is conserved from yeast to hu-
served in other crystal space groups of Chk1KD withmans (Peng et al., 1997; Sanchez et al., 1997; Matsuoka
different molecular packing, suggesting that the apoen-
zyme and the AMP-PNP bound binary complex favor* To whom correspondence should be addressed (e-mail: ping.chen@
agouron.com [P. C.], chun.luo@agouron.com [C. L.]). an open conformation.
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Table 1. Statistics for the Crystallographic Analysis
Crystal Nat1 Nat2 AMP-PNP Hg Au
Internal merging and scaling
Resolution (AÊ ) 1.7 2.1 1.7 2.4 2.0
Reflections measured 162418 46947 107449 64881 125728
Unique reflections 35032 19145 35285 12821 22086
Completeness (%) 93.6 (88.3) 95.4 (94.6) 94.1 (91.1) 95.4 (96.4) 97.5 (84.8)
Average I/s 29.9 (9.0) 15.47 (4.38) 26.4 (12.5) 27.1 (11.6) 33.5 (14.8)
Rsyma 3.2 (18.1) 5.0 (23.3) 3.0 (10.0) 6.0 (13.2) 4.2 (11.8)
SIRSAS analysis
Resolution (AÊ ) 15±3.0 15±3.0
Rcullisb 0.49 0.55
Phasing powerc (SIR/SAS) 2.27/1.98 2.39/1.48
Figure of merit (combined) 0.764
Refinement statistics
Resolution range (AÊ ) 7±1.7 7±2.1 7±1.7
Reflections usedd (F . 1sF) 30132 15804 31794
Total nonhydrogen atoms 2372 2354 2460
Rcryste (%) 21.6 20.8 22.6
Rfreef (%) 23.5 25.0 24.9
Rmsd from ideal bond length (AÊ ) 0.005 0.006 0.010
Rmsd from ideal bond angle (8) 1.30 1.27 1.58
Average B (AÊ 2; all atoms) 28.9 29.7 23.22
Data for the outermost resolution shell are given in parentheses.










j(h)i*100, where I(h)i is the ith measurement of reflection h and IÅ(h) is the mean value of the N equivalent
reflections.
b Rcullis 5 S j j FPH 6 FP j 2 FH(calc) j / S jFPH 6 FP j for all centric reflections.
c Phasing power 5 rms (jFHj/E), where jFHj is the heavy-atom structure factor amplitude and E is the residual lack of closure.
d Number of reflections used in working set.
e Rcryst 5 S jjFobsj 2 jjFcalcj j/SjFobsj, where summation is over data used in the refinement.
f Rfree is the same calculation including the 10% of data excluded from all refinements.
The two lobes of Chk1KD are linked by b69 of the form van der Waals contacts and interact with the hy-
drophobic core of the C-terminal lobe. Interactions ofhinge region and held together at the lobe interface by
an extensive hydrogen-bond network that involves b69, the PW residues may help position the side chain of
Leu206 that forms a hydrophobic pocket with sidethe loop linking aC and b4 of the N-terminal lobe, and
strands b7 and b8 of the C-terminal lobe. Residues from chains from the IEPDIG motif. These motifs could be
important for substrate interaction as described below.this network also form part of the pocket that interacts
with the adenine moiety of AMP-PNP. The conserved Helix aE contains a conserved motif Ala-Gln-X-Phe-
Phe-X-Gln-Leu (residues 107±114), in which the hydro-Lys69 and Lys145 in this hydrogen-bond network in-
teract with the projected side chain of Glu85 that is phobic residues are buried inside the C-terminal lobe.
The side chain of Gln108 projects out of the kinaseconserved at the end of b5 in Chk1 proteins. These
interactions appear to maintain the relative position of domain and forms hydrogen bonds directly or through
a water molecule to backbone atoms of the linker regionthe N-terminal lobe and the Asp-Phe-Gly motif in the
C-terminal lobe, allowing a coordinated movement dur- that follows aI. Although Chk1 sequences diverge in this
linker region, these backbone interactions with Gln108ing lobe closure. Mutation of the equivalent Glu to Asp
in S. pombe Chk1 led to a temperature-sensitive pheno- could still be conserved, thereby helping to anchor the
linker to aE.type (Francesconi et al., 1997). The Chk1KD crystal
structure indicates that disruption of the interactions
formed by this conserved Glu residue could render Chk1 The Activation Loop
Phosphorylation of the activation loop serves as a mo-proteins structurally less stable.
lecular switch for activation of many kinases (Johnson
et al., 1996). For Cdk2, phosphorylation of Thr160 isConserved Motifs
The IEPDIG motif of Chk1KD (residues 96-Ile-Glu-Pro- required for its activity (Russo et al., 1996). There is no
equivalent Thr in the activation loop of human Chk1Asp-Ile-Gly-101) limits aD to a one-turn helix because
Pro98 initiates a tight turn between aD and aE (Figures (Figure 2), indicating that Chk1 is regulated through a
different mechanism than Cdk2. Indeed, the activation1 and 2). This turn interacts with the C terminus of aF
through a backbone hydrogen bond between Asp99 and loop of Chk1KD is already folded into an active confor-
mation (Figure 3).an invariant Gly204. Within this turn, Glu97 forms back-
bone hydrogen bonds with Ile100 and Gly101. Com- The activation loop of Chk1KD appears to be stabi-
lized by its secondary structure and side chain interac-pared with aG of PhK, aG of Chk1KD is positioned differ-
ently (Figure 1B) and is flanked by two pairs of invariant tions (Figures 1 and 2). The antiparallel b strands of b10
and b11 are almost perpendicular to the antiparallel bPW residues (Pro207/Trp208 and Pro230/Trp231) that
Chk1 Kinase Domain Structure
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Figure 1. Chk1KD Crystal Structure and Com-
parison with PhK
(A) A ribbon diagram of the binary complex
structure of Chk1 with AMP-PNP showing
secondary structural elements and loops dis-
cussed in the text. The a helices are shown
in blue, b strands in cyan, catalytic loop in
orange, activation loop in red. AMP-PNP and
sulfate ion are shown as ball and stick mod-
els. The triphosphate moiety of AMP-PNP is
not modeled due to lack of electron density
and the ribose ring is in C29-endo pucker con-
formation. The protein termini are denoted
by N and C. The figure was prepared with
Molscript (Kraulis, 1991).
(B) Stereo diagrams comparing the Ca tracing
of the Chk1KD (open) and PhK (closed). The
Chk1 (purple) and PhK (blue) structures were
superimposed using the C-terminal lobes as
a reference. The Ca tracing of MC-peptide of
PhK is colored orange. Glu110 of PhK and
Arg(P23) of MC-peptide are shown as ball
and stick models. The N-terminal lobes (resi-
dues 2±90 of Chk1KD and residues 14±108
of PhK) can be aligned with an rms deviation
of 1.1 AÊ between positions of Ca atoms. The
C-terminal lobes (residues 91±276 of Chk1KD
and 110±290 of PhK) superimposed with an
rms deviation for Ca atoms of 0.9 AÊ , excluding
aG and connecting loops. The N-terminal
lobe of Chk1KD can be rotated z158 around
the hinge region near Glu91, whose side chain
almost overlaps with the corresponding side
chain of Glu110 in PhK, to the position of
the N-terminal lobe of PhK. The figure was
prepared with Molscript.
strands of b6 and b9 due to a twist at Phe155 between C-terminal lobe through two ion pairs; one is the invari-
ant kinase ion pair between Glu177 and Arg253, theb9 and b10. Phe155 forms backbone hydrogen bonds
with Gly125 in b6 and Arg162 in b11. Between b10 and other is between Lys180 and Glu248. This extra ion pair
restrains the movement of aEF, and in turn the move-b11 is a b turn formed through backbone interaction
between Tyr157 and Arg160. These interactions pack ment of the C terminus of the activation loop. Interest-
ingly, Lys180 and Glu248 are only conserved amongthe N terminus of the activation loop against the catalytic
loop, and position the highly conserved Arg156 and known vertebrate Chk1 proteins.
Phosphorylation of the activation loop provides a neg-Glu161 whose side chains interact with the invariant
His122 of aE and His185 that precedes aF, respectively. ative charge to cluster a set of positively charged side
chains, thereby stabilizing the active conformations ofTogether, these interactions anchor the N-terminal part
of the activation loop to the core of the C-terminal lobe. both the activation and catalytic loops (Johnson et al.,
1996). In Chk1KD, a cluster of positive charges are con-The center of the activation loop interacts with the re-
mainder of the C-terminal lobe through two backbone tributed from Lys54, Arg129, Arg162, and Lys166 with-
out phosphorylation in the activation loop. A sulfate ionhydrogen bonds between Leu164 and Phe184. The C
terminus of the activation loop is supported by aEF, lies close to the corresponding phosphate position of
the phosphothreonine (Thr197) in cyclic AMP±depen-which is anchored at two positions to the core of the
Cell
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Figure 2. Sequence Alignment of Chk1KD and PhK
ClustalW sequence alignment of Chk1 kinase domains of human (hs), mouse (mm), Xenopus (xl), Drosophila (dm), C. elegans (ce), S. cerevisiae
(sc), and S. pombe (sp), as well as human PhK. Secondary structural elements of human Chk1, colored as in Figure 1A, are shown above the
alignment. Residues not modeled in current structures are indicated by a dotted line. The numbers of amino acids are shown on the right.
Invariant residues of Chk1 among these species are in red and human Chk1 residues that are also conserved in other species are in cyan.
Conserved motifs discussed in the text are underlined. Numbers within the PhK sequence indicate the number of residues not shown.
dent kinase (cAPK, PDB code 1ATP) (Knighton et al., to the catalytic residue Asp130. Lys166 also appears to
play a role in determining the substrate selectivity as1991a). This sulfate ion interacts with side chains of
Arg129, Arg162, and Thr153 of Chk1KD. We investigated discussed below. The side chain of Thr153 of Chk1KD
forms a hydrogen bond with the side chain of Lys54whether this sulfate ion could mimic phosphate and
thereby stabilize the activation loop by solving the projected from aC (Figure 3). Lys54 is conserved in all
but S. pombe Chk1 and lies adjacent to Glu55, whichChk1KD structure under sulfate-free conditions. The re-
sultant 2.1 AÊ resolution structure, however, revealed a interacts with Lys38 forming an invariant ion pair of
active kinases. The interaction between Thr153 andnearly identical conformation of the activation loop, ex-
cept for the side chain of the conserved Arg162, which Lys54 may thus play a similar role to the interaction
between the phosphate of phosphorylated Thr197 andturns toward solvent (Figure 3). The nearly identical
structures of the activation loop in Chk1KD with and His87 of cAPK (Knighton et al., 1991a). While Thr153 is
conserved in Chk1 proteins (Thr or Ser), its permutedwithout sulfate ion, together with their well-defined elec-
tron density, underscore the importance of secondary position suggests that it is not a phosphorylation site,
since disruption of the secondary structure of the activa-structure and side chain interactions that stabilize the
Chk1KD activation loop in its active conformation. tion loop would have to accompany phosphorylation of
Thr153.An intriguing feature of Chk1KD is the permuted posi-
tions of Lys166 and Thr153. Kinases that are activated
by phosphorylation of the activation loop have Thr/Tyr Active Site and AMP-PNP Binding
Residues 18±21 at the apex of the glycine-rich loopin the position corresponding to Lys166 of Chk1KD and
Lys/Arg in the position corresponding to Thr153 of between b1 and b2 of Chk1KD showed poor electron
density in the crystal structures. Tyr20 present in humanChk1KD. Kinases that are not controlled by phosphory-
lation of the activation loop such as PhK have other Chk1 corresponds to Tyr15 of Cdc2, phosphorylation
of which inhibits Cdc2 activity (Krek and Nigg, 1991;residues in these corresponding positions (Johnson et
al., 1996). In Chk1KD, Lys166 points its side chain to Parker and Piwnica-Worms, 1992). However, mutation
of Tyr20 in full-length Chk1 to either Glu or Phe does notthe thiol atom of Cys168, and together with the side
chain of Arg129, creates a basic environment for a po- significantly affect its kinase activity (data not shown).
A comparison of Chk1KD with PhK and cAPK in theirtential thiolate ion that could stabilize the positive
charge of Arg129, a highly conserved residue adjacent ternary complexes revealed similar local conformation
Chk1 Kinase Domain Structure
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Figure 3. Stereoview of the Activation Loop and Its Relationship to the Catalytic Loop and Helix aC
Chk1 in purple and PhK in green are superimposed with their C-terminal lobes. The structures displayed correspond to Chk1 residues 50±58
of helix aC, residues 129±132 of the catalytic loop, and residues 148±170 of the activation loop. The displayed Chk1KD structure is from the
sulfate-free crystal. The conformation of Glu182 (E182) of PhK may represent the conformation of Ser173 of S. pombe Chk1 and Asp189 of
S. cerevisiae Chk1 which substitute Lys166 of human Chk1. The figure was prepared with Molscript.
of the catalytic residues (Figure 4). For example, in the catalytic loop (Asp130, Lys132, and Asn135) in Chk1KD
than in PhK or cAPK. Indeed, separation of these resi-N-terminal lobe, the invariant ion pair of active kinases
is present in Chk1KD between Lys38 of b3 and Glu55 dues into two clusters, together with the flexible glycine-
rich loop in Chk1KD, could be responsible for the lackof aC. Despite the more open lobe conformation of
Chk1KD, the relative side chain positions of Lys38, of electron density of the AMP-PNP triphosphate in the
binary complex structure.Glu55, and Asp148 are similar to those of the corre-
sponding residues in cAPK and PhK. This is partly due The adenine and ribose moieties of AMP-PNP are
clearly defined in the Chk1KD binary complex structureto the position of the Asp-Phe-Gly motif, which is closer
to the N-terminal lobe in Chk1KD than in PhK and cAPK. (Figure 5B), but the conformation of the ribose ring in
the present structure would not allow correct orientationThese residues, together with the glycine-rich loop, would
coordinate one of the two magnesium ions and anchor of the ATP phosphates for catalysis. In contrast to the
C39-endo conformation found in active kinase struc-the a and b phosphates of ATP (Johnson et al., 1996).
In the C-terminal lobe, the conformation of the cata- tures, the ribose ring in the Chk1KD binary structure
adopts a C29-endo conformation (Figures 1 and 5B) simi-lytic loop (residues 129±135) of Chk1KD is nearly identi-
cal to that of PhK, with the side chains of Asp130, lar to that seen in the inactive form of Cdk2 (PDB code
1HCK) (De Bondt et al., 1993). However, this is not dueLys132, and Asn135 of Chk1KD nearly superimposable
on the corresponding residues Asp149, Lys151, and to displacement of aC in Chk1KD as is the case in Cdk2.
This C29-endo conformation of ribose probably resultsAsn154 of PhK (Figures 3 and 4). In PhK, Lys151 binds
to the g-phosphate of AMP-PNP and Asn154 chelates from the more open lobe conformation of Chk1KD, as
well as the flexible triphosphate moiety of AMP-PNPthe second magnesium ion that in turn binds to the b
and g phosphates. Thr170 of Chk1KD is conserved in that showed no electron density. Taken together, con-
formational changes in both Chk1KD and the riboseother Ser/Thr protein kinases and contributes to the
specificity of Ser/Thr versus Tyr kinases (Taylor et al., ring of AMP-PNP would be necessary to align the ATP
phosphates for catalysis.1995). The side chain of Thr170 in Chk1KD is within
hydrogen-bonding distance to side chains of Asp130
and Lys132. Thr170 may thus aid to position the car- Structural Basis of Substrate Selectivity
The ordered activation loop of Chk1KD and the overallbonyl of the catalytic residue Asp130. Mutation of
Thr170 in full-length Chk1 to either Ala or Glu abolishes structural resemblance to PhK enabled us to assess
the interactions of a substrate peptide with Chk1KD.Chk1 kinase activity toward Ser216 of human Cdc25C
(data not shown). Residues phosphorylated by Chk1 have been identified
in Cdc25 proteins across species (Peng et al., 1997;A difference between Chk1KD and the active ternary
complexes of PhK and cAPK is the distance between Sanchez et al., 1997; Kumagai et al., 1998; Zeng et al.,
1998). We have modeled the interaction of Chk1KD withthe side chains of residues important for catalysis, and
this appears due to the more open lobe conformation the human Cdc25C peptide Leu-Tyr-Arg-Ser-Pro-Ser-
Met-Pro-Glu (residues 211±219) which spans P25 toof Chk1KD (Figure 4). Specifically, the residues in the
N-terminal lobe and the Asp-Phe-Gly motif (Lys38, P13 based on the ternary complex structure of PhK
with the MC-peptide (PDB code 2PHK) (Lowe et al.,Glu55, and Asp148) of Chk1KD are further apart from the
Cell
686
Figure 4. Catalytic Site of Chk1KD and PhK
(A) Cross section of the catalytic site of
Chk1KD with AMP-PNP. Protein Ca ribbon
representations are shown in purple for
Chk1KD. The side chains of the catalytic site
residues are shown as ball and stick models
and are color-coded by atom type: carbon,
green; nitrogen, blue; oxygen, red. The dis-
tances (AÊ ) along the dotted lines between the
catalytic site residues are shown. In addition,
Lys38Ne is 10 AÊ away from Asp130Od2, com-
pared with 8.2 AÊ in PhK. Asp148Od1 is 6 AÊ
away from Asp130Od2, compared with 3.8 AÊ
in PhK. In Chk1KD, one water molecule is
located between Asp148 and Asp130 and is
hydrogen-bonded to Asp130Od2 and Asn-
135Od1. The figure was prepared with IN-
SIGHT II (INSIGHT II User Guide, 1997, Molec-
ular Simulations Inc., San Diego, CA).
(B) The corresponding section of PhK.
1997). The extended backbone conformation and anti- chain of Leu(P25) fits into a hydrophobic pocket formed
by Phe93, Ile96, Pro98, and Leu206. All of the residuesparallel alignment with respect to the activation loop
appear to be general features for peptides that interact except Leu206 are invariant in Chk1 proteins, and Ile96
and Pro98 are in the conserved IEPDIG motif. The hy-with kinases at the substrate binding site, as has been
observed in the insulin receptor tyrosine kinase ternary drophobic side chain of Met(P11) projects into another
hydrophobic pocket formed by residues of Leu171,complex structure (PDB code 1IR3) (Hubbard, 1997),
and in cAPK ternary complex structure (PDB code 1ATP) Val174, Leu178, Leu179, and Met167 of Chk1KD. Al-
though these residues diverge in Chk1 proteins, the hy-(Knighton et al., 1991b).
Similar to the MC-peptide bound to PhK, the Cdc25C drophobicity of this pocket is conserved (Figure 2).
The Arg(P23) side chain of the modeled Cdc25C pep-peptide was modeled in an extended conformation from
the P25 to P13 positions (Figure 6). In this conforma- tide points toward Glu91 of Chk1KD similar to Arg(P23)
in the MC-peptide of the PhK ternary complex structuretion, the peptide fits into a shallow groove on the surface
of the C-terminal lobe of Chk1KD. The Og atom of Ser(P), (Lowe et al., 1997). Arg is a preferred residue at the P23
position of 14±3±3 binding sites (Yaffe et al., 1997). Anthe presumed nucleophile in the phosphate transfer re-
action, is placed close to an ordered water molecule in extended side chain of Arg(P23) in the Cdc25C peptide
would place the guanidinium group 3 AÊ away from thethe Chk1KD structure. This water molecule forms hydro-
gen bonds with both the Asp130Od2 and Lys132Ne. carboxyl of Glu91. In both ternary complex structures
of cAPK and PhK, the guanidinium of Arg(P23) forms aSuperposition of Chk1KD and PhK shows that this water
molecule would be 3.4 AÊ from the g-phosphorus atom somewhat closer ion-pair (2.5 AÊ ) with the carboxyl of
the corresponding Glu residues (Knighton et al., 1991a,of the AMP-PNP in PhK. This water molecule may thus
approximate the location of the Og atom of Ser(P) during 1991b; Lowe et al., 1997). A more favorable ionic interac-
tion between Arg(P23) and Glu91 would be establishedcatalysis.
The side chains at P25 and P11 of the peptide could in Chk1KD after lobe closure.
The side chain of Ser(P22) does not appear to interactestablish hydrophobic interactions with Chk1KD and an-
chor the peptide at its two ends. The hydrophobic side with Chk1KD, rather it makes a hydrogen bond to the
Chk1 Kinase Domain Structure
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Figure 5. Stereoview of Representative Elec-
tron Density Map
(A) Stereoview of a representative portion of
the experimental density at 1.5 s calculated
to 3.0 AÊ with the use of phases after solvent
flattening. Superposed on the density is the
final refined model.
(B) Difference Fourier map calculated with na-
tive model-derived phases and coefficients
jFo(amppnp)j 2 jFo(native)j to the diffraction of 1.7 AÊ
and contoured at 2.5 s. The triphosphate moi-
ety of AMP-PNP is disordered and is omitted
from the model. No magnesium ions are ob-
served. N6 of adenine forms hydrogen bond
with the main chain carbonyl of Glu85; N1 of
adenine forms hydrogen bond with amide of
Cys87. Not shown in this figure is the interac-
tion of N7 of adenine with the side chain of
Ser147 of Chk1KD via a water molecule. The
figure was prepared with Xfit (McRee, 1992).
backbone carbonyl oxygen of Pro(P21) (Figure 6). In 14±3±3 protein (Muslin et al., 1996). This selectivity is
important for Cdc25 regulation since phosphorylationcomparison, Gln(P22) of the MC-peptide interacts with
Ser188 of PhK, providing an anchor point for the MC- of Ser216 of human Cdc25C confers binding to 14±3±3
proteins, which in turn sequester Cdc25C into the cyto-peptide. This interaction is not available to Chk1KD
since it has an invariant Pro172 in the corresponding plasm (Peng et al., 1997). The structural basis for such
selectivity is suggested by our model: In Chk1KD, theposition of Ser188 in PhK. Pro172 of Chk1KD may thus
contribute to the selectivity for a Ser or Thr residue at two conserved hydrophobic pockets, together with resi-
dues Glu91 and Lys166, are critical for substrate selec-P22 position of the peptide.
The P12 position requires a residue with a small side tivity. In the substrate peptide, hydrophobic side chains
at the P25 and P11 positions, Arg at P23 position, andchain or one that can participate in an abrupt turn in
order to avoid steric clash with Lys166 in Chk1KD. The the steric restriction at the P12 position specify the
interaction with Chk1KD. This model not only is consis-side chain of Lys166 appears to be fixed since its well-
defined positions are identical in the Chk1KD structures tent with all known Chk1 phosphorylation sites, but also
could explain the differences between human and yeastwith or without sulfate. Lys166 is conserved among ver-
tebrate Chk1 proteins. Correspondingly, Pro is found at substrates, as discussed below.
the P12 position in vertebrate Cdc25B and Cdc25C
proteins. Indeed, Pro at P12 position is critical to create Kinase Activity
The Chk1KD structure suggests that phosphorylation ofa consensus 14±3±3 binding site once the Ser(P) is phos-
phorylated (Yaffe et al., 1997). the kinase domain is not required for its activity. Indeed,
Chk1KD (residues 1±289) and the conserved kinase do-Phosphorylation of human Cdc25C by human Chk1
is very selective such that the Ser(P22) is not phosphor- main (residues 1±265) of human Chk1 were over 20-
fold more active than the recombinant full-length Chk1ylated (Peng et al., 1997; Sanchez et al., 1997). Indeed,
phosphorylation of Ser(P22) alone or together with protein toward various substrates including Ser216 of
Cdc25C (Figure 7, comparing lanes 1±3, and data notSer(P) diminished the ability of a Raf peptide to bind
Cell
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Figure 6. Molecular Surface of the Chk1 with Modeled Cdc25C Peptide
The molecular surface of Chk1KD is colored as follows: basic side chains in blue, acidic side chains in red, and nonpolar side chains in violet.
Substrate peptide (Leu-Tyr-Arg-Ser-Pro-Ser-Met-Pro-Glu, residues 211±219 of human Cdc25C) is shown as stick model and color-coded by
atom type: carbon, green; nitrogen, blue; oxygen, red; sulfur, yellow. The figure was prepared with INSIGHT II.
shown). These results suggested that the C-terminal lobe of Chk1KD by z158 around the hinge region near
Glu91 with respect to its C-terminal lobe (Figure 1B).region of Chk1 negatively impacts Chk1 kinase activity.
Phosphorylation of Chk1 induced by DNA damage This rotation would bring the N-terminal lobe of Chk1KD
into the corresponding position of the N-terminal loberequired Chk1 kinase activity in S. pombe, suggesting a
potential role of autophosphorylation in regulating Chk1 of PhK and align the catalytic residues.
Our model for interaction of Chk1KD with a substrateactivity (Walworth and Bernards, 1996). The recombi-
nant full-length Chk1 was readily autophosphorylated peptide suggests a structural basis for the substrate
selectivity of human Chk1. In addition, this model mayand there were multiple phosphorylation sites (Figure
7A). The linker region (residues 261±340 of human Chk1) help to explain different substrate preferences between
human and yeast Chk1 proteins. The amino acid se-can be phosphorylated by Chk1 in vitro (Kaneko et al.,
1999). Indeed, autophosphorylation was observed for quences of the activation loops in yeast Chk1 proteins
suggest that the loops are more flexible in the yeastChk1KD, which contains part of the linker region (resi-
dues 266±289), but not for the shorter conserved kinase proteins compared to human Chk1. Specifically, yeast
Chk1 proteins lack the corresponding ion-pair betweendomain (residues 1±265) (data not shown). Interestingly,
autophosphorylation did not change the kinase activity Lys180 and Glu248 that helps to anchor aEF in human
Chk1. The residue equivalent to Lys166 of Chk1KD isof the recombinant full-length Chk1 (Figure 7, lanes 3±8).
These data further support the notion that Chk1 kinase substituted by Ser173 in S. pombe Chk1 and Asp189 in
S. cerevisiae Chk1. These changes could alter substrateactivity is not regulated by phosphorylation of its kinase
domain. selectivity, since substitution of Lys166 with Ser or Asp
would provide more room for a larger side chain at the
P12 position of the substrate peptide. Indeed, Phe andDiscussion
Thr residues are present at the P12 position in S. pombe
Cdc25 phosphorylation sites.The crystal structures of human Chk1KD apoenzyme and
its AMP-PNP bound binary complex revealed that AMP- Our model also allows prediction of potential Chk1
substrates. Human Chk1 has been shown to phosphory-PNP binding does not cause conformational changes in
Chk1KD. Compared to structures of catalytically active late all human Cdc25 isoforms (Sanchez et al., 1997).
Although the phosphorylation sites have not beenkinases (Knighton et al., 1991a; Johnson et al., 1996;
Russo et al., 1996; Lowe et al., 1997), Chk1KD adopts mapped, there are several Ser residues in Cdc25A and
Cdc25B lying in sequences that match the consensusan open lobe conformation with slight misalignment of
residues critical for catalysis. Lobe closure could be derived from our model. In addition, S. pombe Chk1
phosphorylates the S. pombe Wee1 protein (O'Connellachieved through a simple rotation of the N-terminal
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vitro. Autophosphorylation in vitro may not reflect physi-
ological events induced by DNA damage and phosphor-
ylation of Chk1 by another kinase may be required for
its activation. Alternatively, phosphorylation-dependent
interaction of Chk1 with another protein could contribute
to Chk1 regulation. Chk1 has been shown to interact
with two yeast checkpoint proteins, Cut5 and Crb2 (Saka
et al., 1997), and Crb2 may regulate Chk1 phosphoryla-
tion (Esashi and Yanagida, 1999).
The physiological significance of the finding that
Chk1KD is more active than the full-length Chk1 requires
further investigation of the cellular Chk1 activity. The
C-terminal region may regulate Chk1 kinase activity di-
rectly. This region contains several motifs conserved
within Chk1 proteins but shows no sequence homology
to other proteins. Although this region is not included
in Chk1KD, the crystal structure suggested potential
mechanisms of regulation. The C-terminal region could
control the access of substrates to the Chk1 kinaseFigure 7. Chk1KD Is More Active Than the Full-Length Chk1 and
Autophosphorylation of Full-Length Chk1 Does Not Change Its Ac- domain by interacting with the substrate binding site at
tivity the front of the kinase domain. Such an autoinhibitory
Kinase assays were performed using GST-Cdc25C(200±256) as sub- mechanism has been observed for several kinases in-
strate at 308C for 5 min in the presence of g-32P-ATP (Sanchez et cluding titin (PDB code 1TKI) (Mayans et al., 1998). Like
al., 1997), with 0.05 mM (1.7 mg/ml) of conserved kinase domain
Chk1KD, titin is not regulated through phosphorylation(residues 1±265), 0.05 mM of Chk1KD (residues 1±289), or 0.5 mM
of its activation loop. The titin structure showed that itsof recombinant full-length Chk1. Autophosphorylation of the recom-
C-terminal region extends into the ATP binding site andbinant full-length Chk1 was carried out by incubating the full-length
protein at 36 mM (2 mg/ml) with ATP at 308C for the indicated period blocks substrate peptide binding. However, the short
of time. C-terminal linker visible in Chk1KD structure follows a
(A) Coomassie blue staining of 18 pmol of each protein resolved by different path. In addition, the conserved turn formed by
SDS-PAGE with phosphorylated Chk1 bands marked on the right.
the IEPDIG motif between helices aD and aE of Chk1KD(B) A typical phosphorimage of GST-Cdc25C(200±256) phosphory-
blocks access to the front of the kinase domain. Alterna-lated by Chk1. Chk1KD was 20-fold more active than the full-length
Chk1 whereas the kinase activities of the full-length Chk1 after auto- tively, the C-terminal region of Chk1 could inhibit Chk1
phosphorylation were within 1- to 1.5-fold of the control. kinase activity through interaction with the back of the
kinase domain to maintain the open lobe conformation,
as observed in the current crystal structures. Regulation
et al., 1997; Boddy et al., 1998), in which Ser104 in the
of kinase activity by restraining lobe movement has been
sequence Val-Pro-Arg-Arg-Pro-Ser-Leu-Phe-Asp is a
proposed for Src family kinases (Xu et al., 1997).
consensus Chk1 phosphorylation site. Interestingly, this
The structure of Chk1KD also has practical implica-potential phosphorylation site lies in the highly divergent
tions for anticancer drug discovery since compoundsregulatory region, N-terminal to its kinase domain, and
that abrogate G2 arrest following DNA damage haveis not conserved in human Wee1 (Boddy et al., 1998).
been shown to improve the killing of tumor cells (HartwellIn the S. cerevisiae anaphase inhibitor Pds1, another
and Kastan, 1994; O'Connor and Fan, 1996). This issubstrate of Chk1 (Sanchez et al., 1999), there are sev-
envisaged to occur through limiting the time availableeral consensus Chk1 phosphorylation sites. One of
for repair of damaged DNA. Interestingly, p53-deficientthem, Ser98, in the sequence 93-Asn-Asn-Arg-Ser-Lys-
cancer cells appear to be more susceptible to G2 check-Ser-Phe-Ile-Phe-101, lies next to the destruction box
point abrogation, suggesting such a strategy might(residues 85-Arg-Leu-Pro-Leu-Ala-Ala-Lys-Asp-Asn-93)
prove selective to certain tumors (Fan et al., 1995;of Pds1. Identification of the actual phosphorylation
O'Connor and Fan, 1996). UCN-01, which is under clini-site(s) in the aforementioned proteins would test our
cal evaluation, is also a potent Chk1 kinase inhibitormodel of substrate selectivity for Chk1KD.
(Sarkaria et al., 1999; Graves et al., 2000). Our workThe Chk1KD structure has revealed that the activation
provides a structural base upon which selective inhibi-loop is stabilized in the absence of phosphorylation. In
tors of Chk1 can now be designed. Key residues in theaddition, Tyr20 in the glycine-rich loop of Chk1 did not
catalytic domain to target for kinase inhibition includeappear to play a role in regulating Chk1 kinase activity.
Glu85 and Cys87. Further exploration of selectivity couldTaken together, our results suggested that Chk1 kinase
be obtained through targeting residues that are specialactivity is not regulated by phosphorylation of its kinase
to Chk1, such as Asn59 and Leu84. Our model for inter-domain. Chk1 is phosphorylated after DNA damage and
action of Chk1KD with its substrate peptide also pro-this phosphorylation has been correlated with DNA dam-
vides a structural basis for the design of selective pepti-age±induced G2 arrest (Walworth and Bernards, 1996;
domimetic Chk1 inhibitors. Indeed, accumulation ofSanchez et al., 1997; Kumagai et al., 1998; Martinho et
Cdc25C peptides into cultured cells abrogates check-al., 1998; Sanchez et al., 1999). However, we have not
point control (Suganuma et al., 1999).observed any significant impact of autophosphorylation
on the kinase activity of recombinant Chk1 protein in In conclusion, the Chk1KD structure reveals structural
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sites and five Au sites were identified by difference Fourier synthesisfeatures important for kinase activity, substrate selectiv-
using phases generated from MR partial model and were consistentity, and potential modes of Chk1 kinase regulation. Spe-
with both isomorphous and anomalous difference Patterson maps.cifically, secondary structure and side chain interactions
The positional and thermal parameters and relative occupancies for
stabilize the activation loop of Chk1. We propose that the heavy atom sites were refined using SIR data at 3 AÊ and anoma-
Chk1 becomes fully active upon substrate binding, and lous data at 3.5 AÊ by program PHASES (Furey and Swaminathan,
1990). Sixteen cycles of solvent flattening were then carried outthat its activity is not regulated by phosphorylation
using phases calculated from refined Hg and Au positions. Thewithin the kinase domain. Our results further suggest a
resultant electron density maps showed good backbone densitypotential regulatory role of the less conserved C-termi-
and well-defined side chains for most parts of the protein (Figurenal region of Chk1. In addition, our model of Chk1 sub-
5A). Model building utilized the program FRODO (Jones, 1978). The
strate interaction suggests a consensus sequence for missing loop regions were incorporated into the model using both
phosphorylation by Chk1 that could aid identification of MIR maps and model phased 2Fo-Fc maps. Further refinement using
XPLOR (BruÈ nger, 1992) and then CNS (BruÈ nger et al., 1998) wereadditional Chk1 substrates through which Chk1 affects
continued with both conjugate gradient minimization, simulated an-cell cycle progression. Finally, the Chk1KD crystal struc-
nealing, then followed by manual rebuilding.ture should prove useful in the design of selective inhibi-
Refinement of Nat2 structure was carried out using the refinedtors of Chk1 for pharmacological and therapeutic inves-
Nat1 model but omitting residues 153±170 as well as SO422 anion.tigations of checkpoint regulation. Fo-Fc maps showed well-defined densities for the omitted region
and its conformation is the same as that in Nat1.
Refinement of the binary complex with AMP-PNP proceeded withExperimental Procedures
refining the position of the apoenzyme model (Nat1) as a rigid body
against the complex data using the CNS program. Fo-Fc maps withProtein Expression and Purification
sA (Read, 1986) weighting showed clear density for the adenineHuman Chk1 cDNA was amplified by PCR using Vent plymerase
and ribose components of AMP-PNP (Figure 5B). The conformation(New England Biolabs) from human thymus and testis cDNA (Clon-
of residues forming the binding pocket was checked in simulatedtech). Large scale insect cell fermentation and purification will be
annealing omit-maps before including the adenine and ribose com-described elsewhere (C. L., unpublished data). Chk1KD contains
ponents of AMP-PNP.the conserved kinase domain (residues 1±265), part of the linker
The current apoenzyme model (Nat1) includes all atoms for resi-region (residues 266±289), and 6 His residues at the C-terminus.
dues 2 to 44, 48 to 276, and 181 ordered solvent molecules andChk1KD was purified from insect cells by sequential chromatogra-
one SO422 anion. Residues 45 to 47 and 277 to 289 plus the 63Hisphy using Q-FastFlow (Pharmacia), Ni-NTA-Agarose (Qiagen), ATP-
tag have not been modeled into the current apoenzyme structure.Sepharose (Xu et al., 1997), and HiPrep Sephacryl S-200 (Pharmacia)
The refined Nat2 structure contains the same number of residuescolumns. Purified protein was concentrated to 7±7.5 mg/ml and
and 168 solvent molecules but the SO422 anion is not present. Thestored at 2808C before use.
refined AMP-PNP complex contains the same number of residues
as the apoenzyme structures with 251 ordered solvent moleculesCrystallization and Data Collection
and one SO422 anion.Chk1KD crystals were obtained using a hanging-drop vapor-diffu-
sion method. The Nat1 crystal was obtained by mixing equal vol-
Acknowledgmentsumes of protein solution and reservoir solution of 13% PEG 8000
(w/v), 0.15 M (NH4)2SO4, 0.1 M NaCacodylate (pH 6.8), and 2% glyc-
We thank D. Matthews, Z. Hostomska, R. Love, and D. Knightonerol. The Nat2 crystal was crystallized using reservoir solution of
for their critical comments on the manuscript; M. Gehring for the12% PEG8000 (w/v), 15% iso-propanol, and 0.1 M HEPES (pH 7.5).
expression vector and advice in protein purification; F. MaldonadoBoth conditions produced the exact same form of crystals belonging
for technical support; B. Burke and colleagues of the project teamto the space group P21 with unit cell dimensions a 5 45.2 AÊ , b 5
for valuable discussions.65.7 AÊ , c 5 58.1 AÊ , b 5 93.98. The crystals contain one molecule
per asymmetric unit and 53% solvent by volume. The crystals of
Received November 30, 1999; revised February 23, 2000.binary complex with AMP-PNP were obtained by cocrystallization
first under Nat1 condition in the presence of 1.25 mM AMP-PNP
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